Lai Wang - Jun 16, 2021 Form 4 Insider Report for BeiGene, Ltd. (BGNE)

Role
Global Head of R&D
Signature
/s/ Qing Nian, as Attorney-in-Fact
Stock symbol
BGNE
Transactions as of
Jun 16, 2021
Transactions value $
-$265,583
Form type
4
Date filed
6/21/2021, 04:47 PM
Previous filing
Jun 9, 2021
Next filing
Jun 30, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BGNE Ordinary Shares Award $0 +53.6K +28.98% $0.00 239K Jun 16, 2021 Direct F1
transaction BGNE American Depositary Shares Sale -$266K -802 -100% $331.15 0 Jun 18, 2021 Direct F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BGNE Share Option (Right to Buy) Award $0 +333K $0.00 333K Jun 16, 2021 Ordinary Shares 333K $26.53 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 16, 2021, subject to continued service.
F2 Each American Depositary Share represents 13 Ordinary Shares.
F3 The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 17, 2020, subject to continued service.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $330.78 to $331.62, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F5 The number of securities underlying the option and the exercise price therefor are represented in ordinary shares.
F6 These securities vest over a four-year period as follows: 25% on June 16, 2022, and the remaining in 36 successive equal monthly installments, subject to continued service.